肌萎缩侧索硬化症患者运动后结果的荟萃分析

Q3 Neuroscience
Cara Donohue , Giselle Carnaby , Mary Catherine Reilly , Ryan J. Colquhoun , David Lacomis , Kendrea L. (Focht) Garand
{"title":"肌萎缩侧索硬化症患者运动后结果的荟萃分析","authors":"Cara Donohue ,&nbsp;Giselle Carnaby ,&nbsp;Mary Catherine Reilly ,&nbsp;Ryan J. Colquhoun ,&nbsp;David Lacomis ,&nbsp;Kendrea L. (Focht) Garand","doi":"10.1016/j.ensci.2023.100452","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To systematically evaluate post-exercise outcomes related to function and quality of life in people with ALS.</p></div><div><h3>Methods</h3><p>PRISMA guidelines were used for identifying and extracting articles. Levels of evidence and quality of articles were judged based on <em>The Oxford Centre for Evidence-based Medicine Levels of Evidence</em> and the <em>QualSyst.</em> Outcomes were analyzed with Comprehensive Meta-Analysis V2 software, random effects models, and Hedge's G. Effects were examined at 0–4 months, up to 6 months, and &gt; 6 months. Pre-specified sensitivity analyses were performed for 1) controlled trials vs. all studies and 2) ALSFRS-R bulbar, respiratory, and motor subscales. Heterogeneity of pooled outcomes was computed with the I<sup>2</sup> statistic.</p></div><div><h3>Results</h3><p>16 studies and seven functional outcomes met inclusion for the meta-analysis. Of the outcomes explored, the ALSFRS-R demonstrated a favorable summary effect size and had acceptable heterogeneity and dispersion. While FIM scores demonstrated a favorable summary effect size, heterogeneity limited interpretations. Other outcomes did not demonstrate a favorable summary effect size and/or could not be reported due to few studies reporting outcomes.</p></div><div><h3>Conclusions</h3><p>This study provides inconclusive guidance regarding exercise regimens to maintain function and quality of life in people with ALS due to study limitations (e.g., small sample size, high attrition rate, heterogeneity in methods and participants, etc.). Future research is warranted to determine optimal treatment regimens and dosage parameters in this patient population.</p></div>","PeriodicalId":37974,"journal":{"name":"eNeurologicalSci","volume":"31 ","pages":"Article 100452"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fa/7a/main.PMC9982645.pdf","citationCount":"0","resultStr":"{\"title\":\"A meta-analysis of post-exercise outcomes in people with amyotrophic lateral sclerosis\",\"authors\":\"Cara Donohue ,&nbsp;Giselle Carnaby ,&nbsp;Mary Catherine Reilly ,&nbsp;Ryan J. Colquhoun ,&nbsp;David Lacomis ,&nbsp;Kendrea L. (Focht) Garand\",\"doi\":\"10.1016/j.ensci.2023.100452\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To systematically evaluate post-exercise outcomes related to function and quality of life in people with ALS.</p></div><div><h3>Methods</h3><p>PRISMA guidelines were used for identifying and extracting articles. Levels of evidence and quality of articles were judged based on <em>The Oxford Centre for Evidence-based Medicine Levels of Evidence</em> and the <em>QualSyst.</em> Outcomes were analyzed with Comprehensive Meta-Analysis V2 software, random effects models, and Hedge's G. Effects were examined at 0–4 months, up to 6 months, and &gt; 6 months. Pre-specified sensitivity analyses were performed for 1) controlled trials vs. all studies and 2) ALSFRS-R bulbar, respiratory, and motor subscales. Heterogeneity of pooled outcomes was computed with the I<sup>2</sup> statistic.</p></div><div><h3>Results</h3><p>16 studies and seven functional outcomes met inclusion for the meta-analysis. Of the outcomes explored, the ALSFRS-R demonstrated a favorable summary effect size and had acceptable heterogeneity and dispersion. While FIM scores demonstrated a favorable summary effect size, heterogeneity limited interpretations. Other outcomes did not demonstrate a favorable summary effect size and/or could not be reported due to few studies reporting outcomes.</p></div><div><h3>Conclusions</h3><p>This study provides inconclusive guidance regarding exercise regimens to maintain function and quality of life in people with ALS due to study limitations (e.g., small sample size, high attrition rate, heterogeneity in methods and participants, etc.). Future research is warranted to determine optimal treatment regimens and dosage parameters in this patient population.</p></div>\",\"PeriodicalId\":37974,\"journal\":{\"name\":\"eNeurologicalSci\",\"volume\":\"31 \",\"pages\":\"Article 100452\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fa/7a/main.PMC9982645.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"eNeurologicalSci\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405650223000102\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Neuroscience\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"eNeurologicalSci","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405650223000102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Neuroscience","Score":null,"Total":0}
引用次数: 0

摘要

目的系统评价ALS患者运动后与功能和生活质量相关的结果。方法采用PRISMA指南对文章进行识别和提取。证据水平和文章质量是根据牛津循证医学中心的证据水平和QualSyst来判断的。使用综合荟萃分析V2软件、随机效应模型和Hedge's G.对结果进行分析。在0–4个月、最多6个月和>;6个月。对1)对照试验与所有研究以及2)ALSFRS-R球、呼吸和运动分量表进行了预先指定的敏感性分析。合并结果的异质性用I2统计量进行计算。结果16项研究和7项功能结果符合纳入荟萃分析的条件。在探索的结果中,ALSFRS-R表现出良好的汇总效应大小,并具有可接受的异质性和分散性。虽然FIM评分显示了有利的汇总效应大小,但异质性限制了解释。其他结果没有显示出有利的汇总效应大小和/或由于很少有研究报告结果而无法报告。结论由于研究的局限性(例如,样本量小、损耗率高、方法和参与者的异质性等),本研究为ALS患者维持功能和生活质量的运动方案提供了不确定的指导。未来的研究有必要确定该患者群体的最佳治疗方案和剂量参数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

A meta-analysis of post-exercise outcomes in people with amyotrophic lateral sclerosis

A meta-analysis of post-exercise outcomes in people with amyotrophic lateral sclerosis

A meta-analysis of post-exercise outcomes in people with amyotrophic lateral sclerosis

A meta-analysis of post-exercise outcomes in people with amyotrophic lateral sclerosis

Objective

To systematically evaluate post-exercise outcomes related to function and quality of life in people with ALS.

Methods

PRISMA guidelines were used for identifying and extracting articles. Levels of evidence and quality of articles were judged based on The Oxford Centre for Evidence-based Medicine Levels of Evidence and the QualSyst. Outcomes were analyzed with Comprehensive Meta-Analysis V2 software, random effects models, and Hedge's G. Effects were examined at 0–4 months, up to 6 months, and > 6 months. Pre-specified sensitivity analyses were performed for 1) controlled trials vs. all studies and 2) ALSFRS-R bulbar, respiratory, and motor subscales. Heterogeneity of pooled outcomes was computed with the I2 statistic.

Results

16 studies and seven functional outcomes met inclusion for the meta-analysis. Of the outcomes explored, the ALSFRS-R demonstrated a favorable summary effect size and had acceptable heterogeneity and dispersion. While FIM scores demonstrated a favorable summary effect size, heterogeneity limited interpretations. Other outcomes did not demonstrate a favorable summary effect size and/or could not be reported due to few studies reporting outcomes.

Conclusions

This study provides inconclusive guidance regarding exercise regimens to maintain function and quality of life in people with ALS due to study limitations (e.g., small sample size, high attrition rate, heterogeneity in methods and participants, etc.). Future research is warranted to determine optimal treatment regimens and dosage parameters in this patient population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
eNeurologicalSci
eNeurologicalSci Neuroscience-Neurology
CiteScore
3.50
自引率
0.00%
发文量
45
审稿时长
62 days
期刊介绍: eNeurologicalSci provides a medium for the prompt publication of original articles in neurology and neuroscience from around the world. eNS places special emphasis on articles that: 1) provide guidance to clinicians around the world (Best Practices, Global Neurology); 2) report cutting-edge science related to neurology (Basic and Translational Sciences); 3) educate readers about relevant and practical clinical outcomes in neurology (Outcomes Research); and 4) summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials). eNS accepts most types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered will be from neurology-related fields that are of interest to practicing physicians around the world. Examples include neuromuscular diseases, demyelination, atrophies, dementia, neoplasms, infections, epilepsies, disturbances of consciousness, stroke and cerebral circulation, growth and development, plasticity and intermediary metabolism. The fields covered may include neuroanatomy, neurochemistry, neuroendocrinology, neuroepidemiology, neurogenetics, neuroimmunology, neuroophthalmology, neuropathology, neuropharmacology, neurophysiology, neuropsychology, neuroradiology, neurosurgery, neurooncology, neurotoxicology, restorative neurology, and tropical neurology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信